We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-3.67%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$40.3B
AUM Growth
-$1.82B
(-4.3%)
Cap. Flow
+$332M
Cap. Flow
% of AUM
0.83%
Top 10 Holdings %
Top 10 Hldgs %
25.24%
Holding
2,393
New
237
Increased
785
Reduced
642
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$231M |
| 2 |
Gilead Sciences
GILD
|
+$113M |
| 3 |
PG&E
PCG
|
+$102M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$80.2M |
| 5 |
Allstate
ALL
|
+$64.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$472M |
| 2 |
AbbVie
ABBV
|
+$121M |
| 3 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$69.5M |
| 4 |
Salesforce
CRM
|
+$64.3M |
| 5 |
Home Depot
HD
|
+$62.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.24% |
| 2 | Healthcare | 19.03% |
| 3 | Financials | 13.02% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Industrials | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
ABM Industries
ABM
$2.89B
| $864K | ﹤0.01% |
22,604
| – | – |
|
1152
AAR Corp
AIR
$5.4B
| $864K | ﹤0.01% |
24,133
-2,750
| -10% | -$117K |
|
1153
Papa John's
PZZA
$1.01B
| $863K | ﹤0.01% |
12,333
| – | – |
|
1154
Yelp
YELP
$1.54B
| $860K | ﹤0.01% |
25,360
| – | – |
|
1155
ChargePoint
CHPT
$134M
| $857K | ﹤0.01% |
2,904
+697
| +32% | +$212K |
|
1156
Kohl's
KSS
$2.16B
| $857K | ﹤0.01% |
34,060
-33,575
| -50% | -$979K |
|
1157
Realty Income
O
$61.1B
| $855K | ﹤0.01% |
14,683
-146,025
| -91% | -$10.1M |
|
1158
Clarivate
CLVT
$1.37B
| $854K | ﹤0.01% |
90,900
+850
| +0.9% | +$10.8K |
|
|
MDRX
1159
DELISTED
Veradigm Inc. Common Stock
MDRX
| $854K | ﹤0.01% |
56,100
-32,390
| -37% | -$524K |
|
|
PRFT
1160
DELISTED
Perficient Inc
PRFT
| $850K | ﹤0.01% |
13,075
-1,570
| -11% | -$131K |
|
|
KZR
1161
DELISTED
Kezar Life Sciences
KZR
| $848K | ﹤0.01% |
+9,858
| New | +$958K |
|
1162
Pebblebrook Hotel Trust
PEB
$2.18B
| $848K | ﹤0.01% |
58,470
| – | – |
|
1163
Trane Technologies
TT
$98.8B
| $846K | ﹤0.01% |
5,841
-1,220
| -17% | -$182K |
|
1164
Central Garden & Pet Co Class A
CENTA
$2.43B
| $845K | ﹤0.01% |
30,908
-1,325
| -4% | -$41.5K |
|
|
SEM
1165
DELISTED
Select Medical
SEM
| $843K | ﹤0.01% |
70,760
| – | – |
|
1166
Jack in the Box
JACK
$314M
| $841K | ﹤0.01% |
11,349
-5,660
| -33% | -$429K |
|
1167
Bloomin' Brands
BLMN
$754M
| $839K | ﹤0.01% |
45,790
-5,600
| -11% | -$111K |
|
|
NUVA
1168
DELISTED
NuVasive, Inc.
NUVA
| $835K | ﹤0.01% |
19,057
| – | – |
|
|
HI
1169
DELISTED
Hillenbrand
HI
| $834K | ﹤0.01% |
22,712
| – | – |
|
1170
Vor Biopharma
VOR
$1.06B
| $834K | ﹤0.01% |
+10,475
| New | +$1.03M |
|
|
ETRN
1171
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $832K | ﹤0.01% |
111,290
| – | – |
|
1172
Fortis
FTS
$29.3B
| $829K | ﹤0.01% |
19,951
| – | – |
|
|
BNY
1173
Bank of New York Mellon
BNY
$103B
| $828K | ﹤0.01% |
21,501
-247,810
| -92% | -$10.6M |
|
|
JBTM
1174
JBT Marel
JBTM
$7.35B
| $828K | ﹤0.01% |
9,629
| – | – |
|
1175
Glaukos
GKOS
$9.49B
| $827K | ﹤0.01% |
15,540
-3,030
| -16% | -$156K |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Ensign Peak Advisors held 2,393 positions worth $40.3B, down 4.3% from $42.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ensign Peak Advisors's Q3 2022 filing shows 237 new, 785 increased, 642 reduced and 83 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M. The largest sale was Visa, an estimated $472M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q3 2022 buy was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M.
- Ensign Peak Advisors added most to Mastercard in Q3 2022, an estimated $231M increase.
- Ensign Peak Advisors's biggest Q3 2022 reduction was AbbVie, cutting an estimated $121M.
- Ensign Peak Advisors fully exited Visa in Q3 2022, selling an estimated $472M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $40.3B portfolio in Q3 2022.
- Ensign Peak Advisors opened 237 new positions and closed 83 in Q3 2022.
- Ensign Peak Advisors's portfolio value fell 4.3% quarter-over-quarter to $40.3B.
Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.